Table 2 Tolerating bad health research (part 2): still as many bad trials, but more good ones too
From: Tolerating bad health research (part 2): still as many bad trials, but more good ones too
No. of trials(n = 140) | Percentage | ||
|---|---|---|---|
Country | UK | 98 | 70 |
Canada | 37 | 26 | |
Ireland | 5 | 4 | |
Year trial published | 2020–2011 | 60 | 43 |
2010–2001 | 33 | 24 | |
2000–1991 | 20 | 14 | |
1990–1981 | 17 | 12 | |
1980–1971 | 8 | 6 | |
1970–1961 | 2 | 1 | |
No. of trials per review group | Percentage | ||
Cochrane review group(s) | Common Mental Disorder | 27 | 19 |
Incontinence; Bone Joint Muscle Trauma | 9 | 13 | |
Cochrane Developmental, Psychosocial Learning Problems | 8 | 6 | |
Neuromuscular; Effective Practice Care | 7 | 10 | |
Consumers & Communication; Public Health; STIs | 5 | 11 | |
Dementia Cognitive Improvement; Epilepsy; Musculoskeletal; Skin | 4 | 11 | |
Airways; Anaesthesia; Breast Cancer; Colorectal; Oral Health; Schizophrenia | 3 | 13 | |
Acute Respiratory Infections; Back and Neck; Metabolic Endocrine Disorders; Multiple Sclerosis; Neonatal; Pain Palliative Support; Stroke; Tobacco Addiction | 2 | 11 | |
Drugs Alcohol; Gynaecological Fertility; Infectious Disease; Lung cancer; Kidney Transplants; Work; Wounds | 1 | 5 | |
No. of trials | Percentage | ||
No. of participants in the trial | 0–99 | 79 | 56 |
100–199 | 20 | 14 | |
200–299 | 12 | 9 | |
300–399 | 6 | 4 | |
400–999 | 15 | 11 | |
> 1000 | 7 | 5 | |
Not reported | 1 | 1 | |